MedPath

NEPTAZANE TABLETS 50MG

NEPTAZANE TABLETS 50MG

Discontinued
DIN Number

02238071

Drug Class

Human

Market Date

Dec 23, 1998

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238071
AIG Number0107657001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EC05 METHAZOLAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification52:40.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

METHAZOLAMIDEActive
Strength: 50 MG
Monograph: METHAZOLAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.